Dawnrays Pharmaceutical (Holdings) Limited (“Dawnrays Pharma”) is a pharmaceutical company listed on the main board of the Hong Kong Stock Exchange. It is principally engaged in the development, manufacturing and sales of cephalosporin antibiotics and system specific medicines. Dawnrays Pharma has established leading product brands in the cardiovascular, anti-HBV, anti-allergic and the third generation cephalosporin antibiotics medicine fields. The group will shoulder high sense of responsibility and adhere to professional attitude, creative ideas, ambitious vision and sound steps so as to focus on operating the group business and continuously pursue breakthrough as well as make great contribution to the human health!